Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DE7Q3R
|
|||
| Drug Name |
FID-007
|
|||
| Indication | Aggressive cancer [ICD-11: 2A00-2F9Z; ICD-10: R45.6; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Fulgent Pharma Temple City, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03537690) A Phase I Study of FID-007 in Patients With Advanced Solid Tumors. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.